IT1110751B - Derivati della prostaglandina - Google Patents

Derivati della prostaglandina

Info

Publication number
IT1110751B
IT1110751B IT19091/79A IT1909179A IT1110751B IT 1110751 B IT1110751 B IT 1110751B IT 19091/79 A IT19091/79 A IT 19091/79A IT 1909179 A IT1909179 A IT 1909179A IT 1110751 B IT1110751 B IT 1110751B
Authority
IT
Italy
Prior art keywords
prostaglandine derivatives
prostaglandine
derivatives
Prior art date
Application number
IT19091/79A
Other languages
English (en)
Other versions
IT7919091A0 (it
Inventor
Enomoto Satoru
Asano Kiro
Tamura Humio
Tanaka Hiromitsu
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53009652A external-priority patent/JPS5850236B2/ja
Priority claimed from JP10443478A external-priority patent/JPS5845440B2/ja
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of IT7919091A0 publication Critical patent/IT7919091A0/it
Application granted granted Critical
Publication of IT1110751B publication Critical patent/IT1110751B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT19091/79A 1978-01-31 1979-01-05 Derivati della prostaglandina IT1110751B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53009652A JPS5850236B2 (ja) 1978-01-31 1978-01-31 プロスタグランジン類↓−ステロイドホルモン結合体
JP10443478A JPS5845440B2 (ja) 1978-08-29 1978-08-29 プロスタグランジン誘導体とその製造方法及び薬剤

Publications (2)

Publication Number Publication Date
IT7919091A0 IT7919091A0 (it) 1979-01-05
IT1110751B true IT1110751B (it) 1986-01-06

Family

ID=26344419

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19091/79A IT1110751B (it) 1978-01-31 1979-01-05 Derivati della prostaglandina

Country Status (16)

Country Link
US (1) US4198405A (it)
AR (1) AR223473A1 (it)
AU (1) AU519132B2 (it)
CA (1) CA1125742A (it)
CH (1) CH639668A5 (it)
DE (1) DE2900061C2 (it)
DK (1) DK159455C (it)
ES (1) ES477216A1 (it)
FI (1) FI68811C (it)
FR (1) FR2422686A1 (it)
GB (1) GB2015528B (it)
IL (1) IL56430A (it)
IT (1) IT1110751B (it)
NL (1) NL187485C (it)
NO (1) NO151087C (it)
SE (5) SE441006B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318908A (en) * 1979-12-06 1982-03-09 Kureha Kagaku Kogyo Kabushiki Kaisha Methylated prostaglandin derivatives
US4784960A (en) * 1981-09-24 1988-11-15 Peter S. Brune Process for preparation of control for use in progesterone receptor
US4423151A (en) * 1981-09-24 1983-12-27 Peter S. Brune Process for preparation of control for use in estrogen receptor tests
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US8337891B2 (en) * 2003-07-03 2012-12-25 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
JP2007517878A (ja) * 2004-01-15 2007-07-05 ワーナー・チルコット・カンパニー・インコーポレーテッド エチニルエストラジオールのジ−ステロイド型プロドラッグ
JP2007517877A (ja) * 2004-01-15 2007-07-05 ワーナー・チルコット・カンパニー・インコーポレーテッド エストラジオールのジ−ステロイド型プロドラッグ
ES2523045T3 (es) * 2005-07-12 2014-11-20 Warner Chilcott Company, Llc Derivado éster de etinil estradiol
CN101228177A (zh) * 2005-07-12 2008-07-23 沃纳奇尔科特公司 雌二醇的3-酯前药
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
JP2023524494A (ja) 2020-05-01 2023-06-12 リップル セラピューティクス コーポレーション 眼障害を処置するためのヘテロ二量体組成物と方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839409A (en) * 1958-05-28 1974-10-01 Kemiska Inst Karolinska I Pge3 esters and alkanoates
US3732261A (en) * 1971-12-03 1973-05-08 Nelson Res & Dev Steroid compounds
JPS5829318B2 (ja) * 1974-03-11 1983-06-22 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ホウホウ

Also Published As

Publication number Publication date
SE8305321L (sv) 1983-09-29
SE8305323D0 (sv) 1983-09-29
FR2422686B1 (it) 1982-11-19
GB2015528B (en) 1982-10-27
DE2900061C2 (de) 1982-04-01
CH639668A5 (de) 1983-11-30
SE7900086L (sv) 1979-08-01
SE8305322L (sv) 1983-09-29
SE441006B (sv) 1985-09-02
SE448873B (sv) 1987-03-23
US4198405A (en) 1980-04-15
SE8305322D0 (sv) 1983-09-29
SE8305321D0 (sv) 1983-09-29
AR223473A1 (es) 1981-08-31
DK6179A (da) 1979-08-01
ES477216A1 (es) 1980-03-01
FI790281A7 (fi) 1979-08-01
CA1125742A (en) 1982-06-15
DK159455C (da) 1991-03-18
DE2900061A1 (de) 1979-08-02
SE8305324L (sv) 1983-09-29
NO151087C (no) 1985-02-06
NO790297L (no) 1979-08-01
DK159455B (da) 1990-10-15
AU4254578A (en) 1979-08-09
GB2015528A (en) 1979-09-12
SE448870B (sv) 1987-03-23
NL7900071A (nl) 1979-08-02
IL56430A (en) 1984-03-30
AU519132B2 (en) 1981-11-12
SE448871B (sv) 1987-03-23
IL56430A0 (en) 1979-03-12
NL187485B (nl) 1991-05-16
NO151087B (no) 1984-10-29
FI68811B (fi) 1985-07-31
FR2422686A1 (fr) 1979-11-09
NL187485C (nl) 1991-10-16
SE8305324D0 (sv) 1983-09-29
SE448872B (sv) 1987-03-23
SE8305323L (sv) 1983-09-29
IT7919091A0 (it) 1979-01-05
FI68811C (fi) 1985-11-11

Similar Documents

Publication Publication Date Title
IT1092170B (it) Derivati della morfolina
IT1192347B (it) Derivati di alchilendiamine
IT7919369A0 (it) Derivati della tienoidantoina ad azione terapeutica.
DE2964681D1 (de) 4-amino-3-sulfonamido pyridine derivatives
IT1127231B (it) Derivati spiro-policiclicimidazolidinadionici
IT1110751B (it) Derivati della prostaglandina
IT7819738A0 (it) Derivati della trimetilchinolina.
IT1110097B (it) Derivati della cumarina
IT1150203B (it) Derivati della naftiridina
IT1122489B (it) Derivati di cloroambucile
IT1193842B (it) Derivati della cisteina
IT8022594A0 (it) Derivati della paromomicina.
IT8147608A0 (it) Derivati della bis-moranolina
IT1188839B (it) Derivati di arabino-furanosil-citosina
IT1092334B (it) Derivati della ossidiazolo-pirimidina
IT1195305B (it) Derivati della naftiridina
DK152979A (da) Pyridinderivater
DK143979A (da) Chromanonderivater
IT1114249B (it) Derivato della tetraidro-isochinolina
IT1209839B (it) Derivati della cinnamil moranolina
IT1174314B (it) Derivati della gentamicina
IT1098350B (it) Derivati prostaglandinici
DK149809C (da) 1-alkylsubstituerede pyrazolderivater
IT1115134B (it) Derivati di fenilpirolo
IT1089247B (it) 5-6-di idro-prostaciclina derivati